Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization, and intracytoplasmic sperm injection

Fertility and Sterility

Volumn 90, Issue 3, 2008, Pages 546-550

  Buckett, William M ^a   Chian, Ri Cheng ^a   Dean, Nicola L ^a   Sylvestre, Camille ^a   Holzer, Hananel E G ^a   Tan, Seang Lin ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

ICSI; IVF; IVM; miscarriage; pregnancy loss

Indexed keywords

ARTICLE; CONTROLLED STUDY; ECTOPIC PREGNANCY; FEMALE; FERTILIZATION IN VITRO; FETUS WASTAGE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MAJOR CLINICAL STUDY; OOCYTE MATURATION; OVARY POLYCYSTIC DISEASE; PREGNANCY OUTCOME; PREGNANCY RATE; PREGNANCY TERMINATION; PREGNANT WOMAN; PRIORITY JOURNAL; SPONTANEOUS ABORTION; STILLBIRTH; TERTIARY HEALTH CARE; TRISOMY;

ABORTION, SPONTANEOUS; ADULT; FEMALE; FERTILIZATION IN VITRO; HUMANS; INCIDENCE; INFERTILITY; PREGNANCY; QUEBEC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME;

EID: 51549100624     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.06.107     Document Type: Article

References (32)

1. Trounson A., Wood C., and Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril 62 (1994) 353-362
2. Chian R.C., Gulekli B., Buckett W.M., and Tan S.L. Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome. N Engl J Med 341 (1999) 1624-1626
3. Mikkelsen A.L., Smith S.D., and Lindenberg S. In vitro maturation of human oocytes from regularly menstruating women may be successful without follicle stimulation hormone priming. Hum Reprod 14 (1999) 1847-1851
4. Cha K.Y., Han S.Y., Chung H.M., Choi D.H., Lim J.M., Lee W.S., et al. Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome. Fertil Steril 73 (2000) 978-983
5. Soderstrom-Anttila V., Makinen S., Tuuri T., and Suikkari A.M. Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients. Hum Reprod 20 (2005) 1534-1540
6. MacDougall M.J., Tan S.L., Balen A., and Jacobs H.S. A controlled study comparing patients with and without polycystic ovaries undergoing in vitro fertilization. Hum Reprod 8 (1993) 233-237
7. Buckett W.M., Chian R.C., and Tan S.L. Can we eliminate severe ovarian hyperstimulation syndrome? Not completely. Hum Reprod 20 (2005) 2367
8. Li Y., Feng H.L., Cao Y.C., Zheng G.J., Yang Y., Mullen S., et al. Confocal microscopic analysis of the spindle and chromosome configurations of human oocytes matured in vitro. Fertil Steril 85 (2006) 827-832
9. Piquette G.N. The in vitro maturation (IVM) of human oocytes for in vitro fertilization (IVF): is it time yet to switch to IVM-IVF?. Fertil Steril 85 (2006) 833-835
10. Trounson A. Spindle abnormalities in oocytes. Fertil Steril 85 (2006) 838
11. Trimarchi J.R., and Keefe D.L. Assessing the quality of oocytes derived from in vitro maturation: are we looking under the lamppost?. Fertil Steril 85 (2006) 839-840
12. Cha K.Y., Chung H.M., Lee D.R., Kwong H., Chung M.K., Park L.S., et al. Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer. Fertil Steril 83 (2005) 1461-1465
13. Le Du A., Kaddoch J., Bourcigaux N., Doumerc S., Chevalier N., Franchin R., et al. In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience. Hum Reprod 20 (2005) 420-424
14. Lin H.Y., and Hwang J.L. In vitro maturation of human oocytes. Taiwan J Obstet Gynecol 45 (2006) 95-99
15. Child T.J., Phillips S.J., Abdul-Jalil A.K., Gulekli B., and Tan S.L. A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries. Obstet Gynecol 100 (2002) 665-670
16. Buckett W.M., Chian R.C., and Tan S.L. Human chorionic gonadotropin for in vitro oocyte maturation: does it improve the endometrium or implantation?. J Reprod Med 49 (2004) 93-98
17. Tan S.L., Child T.J., and Gulekli B. In vitro maturation and fertilization of oocytes from unstimulated ovaries: predicting the number of immature oocytes retrieved by early follicular phase ultrasonography. Am J Obstet Gynecol 186 (2002) 684-689
18. Chian R.C., Buckett W.M., Tulandi T., and Tan S.L. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod 15 (2000) 165-170
19. Biljan M.M., Mahutte N.G., Dean N., Hemmings R., Bissonnette F., and Tan S.L. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil Steril 70 (1998) 1063-1069
20. Tan S.L., Maconochie N., Doyle P., Campbell S., Balen A., Bekir J., et al. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am J Obstet Gynecol 171 (1994) 513-520
21. Kelly S.M., Pirwany I.R., Phillips S.J., and Tan S.L. Microdose gonadotrophin-releasing hormone agonist (GnRH-a) flare protocol compared with standard long protocol GnRH-a for ovarian stimulation in patients undergoing in vitro fertilization. Fertil Steril 78 Suppl 2 (2002) S234
22. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
23. Homburg R. Pregnancy complications in PCOS. Best Pract Res Clin Endocrinol Metab 20 (2006) 281-292
24. MacGregor A.H., Johnson J.E., and Bunde C.A. Further clinical experience with clomiphene citrate. Fertil Steril 19 (1968) 616-622
25. Kousta E., White D.M., and Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 3 (1997) 359-365
26. Hamilton-Fairley D., Kiddy D., Watson H., Paterson C., and Franks S. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br J Obstet Gynaecol 99 (1992) 128-131
27. Homburg R., Levy T., Berkovitz D., Farchi J., Feldberg D., Ashkenazi J., et al. Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovary syndrome. Fertil Steril 59 (1993) 527-531
28. Balen A.H., Tan S.L., MacDougall J., and Jacobs H.S. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod 8 (1993) 959-964
29. Winter E., Wang J., Davies M.J., and Norman R. Early pregnancy loss following assisted reproductive technology treatment. Hum Reprod 17 (2002) 3220-3223
30. Wang J.X., Davies M.J., and Norman R.J. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod 16 (2001) 2606-2609
31. Wang J.X., Davies M.J., and Norman R.J. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res 10 (2002) 551-554
32. Thatcher S.S., and Jackson E.M. Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin. Fertil Steril 85 (2006) 1002-1009